Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atherogenic modified LDL in diabetes

I A Sobenin1, V V Tertov, A N Orekhov

  • 1Institute of Experimental Cardiology, Russian Cardiology Research Center, Moscow.

Diabetes
|July 1, 1996
PubMed
Summary

Diabetic patients exhibit modified Low-Density Lipoprotein (LDL) that directly promotes atherosclerosis. This atherogenic LDL is characterized by being smaller, denser, and glycated, leading to cellular cholesterol accumulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.

Doklady. Biochemistry and biophysics·2024
Same author

Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2023
Same author

Molecular Pathogenesis and the Possible Role of Mitochondrial Heteroplasmy in Thoracic Aortic Aneurysm.

Life (Basel, Switzerland)·2021
Same author

Animal models of human atherosclerosis: current progress.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2020
Same author

Correction to: Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2019

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • Diabetic patients exhibit increased risk of atherosclerosis.
  • Low-Density Lipoprotein (LDL) modifications are implicated in atherogenesis.
  • Specific LDL alterations in diabetes require further elucidation.

Purpose of the Study:

  • To characterize the atherogenic modifications of LDL in diabetic patients.
  • To identify specific LDL subfractions responsible for increased atherogenicity.
  • To investigate the biochemical and physical properties of modified LDL.

Main Methods:

  • Affinity chromatography using Ricinus communis agglutinin-agarose to separate LDL fractions.
  • Analysis of sialic acid and fructosyl lysine levels in LDL subfractions.
  • Cell culture studies using human aortic intima cells to assess atherogenic effects.
  • Electrophoretic mobility, density gradient ultracentrifugation, and gel electrophoresis to determine LDL properties.

Main Results:

  • LDL from diabetic patients directly increased cellular cholesterol accumulation.
  • A higher proportion of bound LDL (desialylated, glycated) was found in diabetics.
  • Bound LDL, unlike unbound LDL, induced cholesterol accumulation in cultured cells.
  • Bound LDL exhibited lower sialic acid, higher fructosyl lysine, reduced neutral lipids, and altered physical characteristics (smaller, denser, more electronegative).

Conclusions:

  • The in vivo modified atherogenic LDL subfraction in diabetic patients is small, dense, electronegative, desialylated, and glycated.
  • These specific LDL modifications contribute directly to the increased atherogenic risk in diabetes.
  • Understanding these LDL alterations is crucial for developing targeted therapies for diabetic cardiovascular complications.

Related Experiment Videos